| The efficacy and safety of anti-PD-1/PD-L1 antibodies for treatment of advanced or refractory cancers: a meta-analysis T Zhang, J Xie, S Arai, L Wang, X Shi, N Shi, F Ma, S Chen, L Huang, ... Oncotarget 7 (45), 73068, 2016 | 130 | 2016 |
| Tyrosine kinase inhibitors increase MCL1 degradation and in combination with BCLXL/BCL2 inhibitors drive prostate cancer apoptosis S Arai, O Jonas, MA Whitman, E Corey, SP Balk, S Chen Clinical Cancer Research 24 (21), 5458-5470, 2018 | 54 | 2018 |
| Screening for prostate cancer: History, evidence, controversies and future perspectives toward individualized screening K Ito, R Oki, Y Sekine, S Arai, Y Miyazawa, Y Shibata, K Suzuki, ... International Journal of Urology 26 (10), 956-970, 2019 | 48 | 2019 |
| Downregulation of Dipeptidyl Peptidase 4 Accelerates Progression to Castration-Resistant Prostate Cancer JW Russo, C Gao, SS Bhasin, OS Voznesensky, C Calagua, S Arai, ... Cancer research 78 (22), 6354-6362, 2018 | 48 | 2018 |
| MARCH5 mediates NOXA-dependent MCL1 degradation driven by kinase inhibitors and integrated stress response activation S Arai, A Varkaris, M Nouri, S Chen, L Xie, SP Balk Elife 9, e54954, 2020 | 41 | 2020 |
| Chemoprevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia (HGPIN): a systematic review and adjusted indirect treatment comparison K Cui, X Li, Y Du, X Tang, S Arai, Y Geng, Y Xi, H Xu, Y Zhou, W Ma, ... Oncotarget 8 (22), 36674, 2017 | 39 | 2017 |
| Effect of castration monotherapy on the levels of adrenal androgens in cancerous prostatic tissues S Arai, Y Miyashiro, Y Shibata, Y Tomaru, M Kobayashi, S Honma, ... Steroids 76 (3), 301-308, 2011 | 39 | 2011 |
| Androgen receptor and MYC equilibration centralizes on developmental super-enhancer H Guo, Y Wu, M Nouri, S Spisak, JW Russo, AG Sowalsky, MM Pomerantz, ... Nature communications 12 (1), 7308, 2021 | 38 | 2021 |
| Targeting the androgen receptor and overcoming resistance in prostate cancer DJ Einstein, S Arai, SP Balk Current opinion in oncology 31 (3), 175, 2019 | 35 | 2019 |
| YM155 reverses rapamycin resistance in renal cancer by decreasing survivin H Koike, T Nitta, Y Sekine, S Arai, Y Furuya, M Nomura, H Matsui, ... Journal of cancer research and clinical oncology 140, 1705-1713, 2014 | 35 | 2014 |
| New quantification method for estradiol in the prostatic tissues of benign prostatic hyperplasia using liquid chromatography–tandem mass spectrometry S Arai, Y Miyashiro, Y Shibata, B Kashiwagi, Y Tomaru, M Kobayashi, ... Steroids 75 (1), 13-19, 2010 | 32 | 2010 |
| Direct Regulation of Prostate Blood Flow by Vascular Endothelial Growth Factor and Its Participation in the Androgenic Regulation of Prostate Blood Flow in Vivo Y Shibata, B Kashiwagi, S Arai, Y Fukabori, K Suzuki, S Honma, ... Endocrinology 145 (10), 4507-4512, 2004 | 26 | 2004 |
| Simvastatin in combination with meclofenamic acid inhibits the proliferation and migration of human prostate cancer PC‑3 cells via an AKR1C3 mechanism Y Sekine, H Nakayama, Y Miyazawa, H Kato, Y Furuya, S Arai, H Koike, ... Oncology letters 15 (3), 3167-3172, 2018 | 25 | 2018 |
| Efficacy of indocyanine green angiography on microsurgical subinguinal varicocelectomy Y Shibata, S Kurihara, S Arai, H Kato, T Suzuki, Y Miyazawa, H Koike, ... Journal of Investigative Surgery 30 (4), 247-251, 2017 | 18 | 2017 |
| A case of emphysematous pyelonephritis in a renal allograft S Arai, T Makino, H Okugi, M Hasumi, Y Shibata, M Hatori, K Suzuki Transplantation 81 (2), 296-297, 2006 | 18 | 2006 |
| Autocrine canonical Wnt signaling primes noncanonical signaling through ROR1 in metastatic castration-resistant prostate cancer F Ma, S Arai, K Wang, C Calagua, AR Yuan, L Poluben, Z Gu, JW Russo, ... Cancer Research 82 (8), 1518-1533, 2022 | 17 | 2022 |
| Psychological distress in men with prostate cancer and their partners before and after cancer diagnosis: a longitudinal study A Oba, N Nakaya, K Saito-Nakaya, M Hasumi, H Takechi, S Arai, ... Japanese journal of clinical oncology 47 (8), 735-742, 2017 | 17 | 2017 |
| Methodological approach to the intracrine study and estimation of DHEA and DHEA-S using liquid chromatography–tandem mass spectrometry (LC–MS/MS) Y Shibata, S Arai, S Honma The Journal of steroid biochemistry and molecular biology 145, 193-199, 2015 | 17 | 2015 |
| Impact of pre‐treatment prostate tissue androgen content on the prediction of castration‐resistant prostate cancer development in patients treated with primary androgen … Y Shibata, K Suzuki, S Arai, Y Miyoshi, S Umemoto, N Masumori, ... Andrology 1 (3), 505-511, 2013 | 17 | 2013 |
| Androgen receptor splice variant 7 functions independently of the full length receptor in prostate cancer cells J Liang, L Wang, L Poluben, M Nouri, S Arai, L Xie, OS Voznesensky, ... Cancer Letters 519, 172-184, 2021 | 15 | 2021 |
Fen MaBeth Israel Deaconess Medical Center在 bidmc.harvard.edu 的电子邮件经过验证
